Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Horak

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancerP Sabbatini, S M Larson, A Kremer, et al.
Cell|October 18, 1996
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP geneT Holtschke, J Löhler, Y Kanno, et al.
Blood|May 23, 2001
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trialJ E Karp, J E Lancet, S H Kaufmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancerP Sabbatini, S M Larson, A Kremer, et al.
Cell|October 18, 1996
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP geneT Holtschke, J Löhler, Y Kanno, et al.
Blood|May 23, 2001
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trialJ E Karp, J E Lancet, S H Kaufmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
Pageof 9